Deep neural networks will allow signal transfer of nerve cells to be analyzed in real time in the future. That is the result ...

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

Various diseases can be treated by stimulating the vagus nerve in the ear with electrical signals. However, this technique does not always work. A study has now shown: The electrical signals must be ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

Some health problems, including chronic pain, inflammation and neurological diseases, can be treated by nerve stimulation, ...

Explore the breakthrough in vagus nerve stimulation enhancing treatment for chronic illnesses by syncing with natural rhythms ...

Deep neural networks will allow signal transfer of nerve cells to be analyzed in real time in future. That is the result of a study conducted by ...

It’s made up of the body’s many nerve cells. These cells work together in a network that sends and receives signals from one part of the body to another. Nerve cells take in information ...